Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024
2024
· Centers for Disease Control and Prevention (CDC),
· Vanderbilt University,
· Seattle Children's Hospital,
· Baylor College of Medicine,
· University of Rochester
This study examines the effectiveness of nirsevimab, a monoclonal antibody, in preventing RSV-related hospitalizations in infants during their first RSV season. Conducted from October 2023 …
Ask aRCie
Monoclonal Antibodies for Prophylaxis and Treatment of Respiratory Viral Infections
This article discusses the use of monoclonal antibodies (mAbs) to prevent and treat respiratory viral infections, especially in people with weak immune systems. It describes …
Respiratory Syncytial Virus-An Update for Prenatal and Primary Health Providers
2023
· University of Washington,
· State University of New York - Upstate Medical University,
· Seattle Children's Hospital
This article provides an update on respiratory syncytial virus (RSV) for prenatal and primary health providers. It emphasizes the lack of data on RSV infection …
Early Experiences With Nirsevimab: Perspectives From Newborn Hospitalists
2024
· Yale School of Medicine,
· Stanford University,
· Seattle Children's Hospital,
· The University of Chicago Medicine,
· Nationwide Children's Hospital,
· Yale University
This article discusses the implementation of newly developed nirsevimab into clinical practice. Approved in July 2023, it is costly and has supply issues. Hospitals struggle …